BASF Approached Evonik About a Takeover That Would Reshape Europe's Chemicals Industry

BASF, the Ludwigshafen-based group that is the world's largest chemicals maker by revenue, has approached its German rival Evonik Industries about a potential takeover, in what would be one of the biggest steps yet toward consolidating Europe's fragmented chemicals sector. GuruFocus's report on the approach puts Evonik's enterprise value, including net debt, at around twelve billion euros against a current market capitalisation near 8.4 billion euros, meaning any eventual offer would need to clear a meaningful premium to win over shareholders.

Who actually has to say yes

The deal's fate rests less with Evonik's board than with the RAG-Stiftung, a foundation originally set up to manage the legacy liabilities of Germany's coal mining industry, which holds a controlling 44 per cent stake in the company. Evonik's own confirmation of the approach, reported after its shares jumped more than 7 per cent in Frankfurt trading, stressed that the contact from BASF was non-binding and that no formal talks were under way, a standard disclosure posture for a company reacting to a leaked approach rather than announcing an agreed transaction.

Two companies, overlapping businesses

BASF and Evonik compete directly in specialty chemicals, catalysts and additives used across the automotive, construction and consumer goods industries, and BASF has reportedly been consulting investment banks on possible deal structures for months before the approach became public. A combination on this scale would concentrate a significant share of European specialty chemicals capacity in a single group at a moment when the industry as a whole has been squeezed by high European energy costs, cheaper competition from Chinese and Gulf producers, and years of thin margins that have already pushed several mid-sized European chemicals makers toward mergers or plant closures.

A premium BASF can afford, market willing

BASF's own market valuation, at roughly 47 billion euros, gives it the scale to absorb Evonik without straining its balance sheet in the way a smaller acquirer would face, but the market's initial reaction split the two stocks in opposite directions, Evonik shares rising sharply on takeover hopes while BASF's slipped nearly 2 per cent, a pattern typical of acquirer stocks pricing in the cost of a deal before its terms are known. Both companies have declined to confirm a timetable, and people close to the discussions have cautioned that the preliminary contact may not lead to a definitive agreement at all.